# Somite Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/somite-therapeutics

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.somite.ai
- Total disclosed funding: $48M
- Latest round: Series A (May 13, 2025)
- Investors on record: 8

## About

Based in Massachusetts, US, and founded in 2023, Somite Therapeutics, Inc. operates as a biotechnology research company that uses AI to produce human tissue for cell therapies, ultimately aiming to cure various diseases by addressing cell population deficiencies. The company was co-founded by Micha Breakstone (CEO), Allon Klein, and Cliff Tabin. In May 2025, Somite Therapeutics, Inc. raised USD 47.5 million in series A funding led by new investor Khosla Ventures, with participation from other new investors SciFi VC, Chan Zuckerberg Initiative, Fusion Fund, Ajinomoto, Pitango HealthTech, TechAviv and Harpoon Ventures. Individual investors also participated in the round. The company's AlphaStem platform focuses on developing AI foundation models to create human tissue at scale for diseases like diabetes, obesity, and muscular dystrophies. Somite's innovative approach involves building digital twins of the embryo, which are computational models mirroring real embryonic development, to guide cell differentiation protocols and optimize production variability in cell replacement therapies. The company will use the May 2025 funding for further development of DeltaStem.

## Funding rounds

- Series A, May 13, 2025, $48M — Khosla Ventures, Fusion Fund, Chan Zuckerberg Initiative, SciFi VC, TechAviv, Harpoon Ventures, Ajinomoto, Pitango Healthtech

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- Fusion Fund (https://capitalatlas.ai/funds/fusion-fund) — Series A
- Chan Zuckerberg Initiative (https://capitalatlas.ai/funds/chan-zuckerberg-initiative) — Series A
- SciFi VC (https://capitalatlas.ai/funds/scifi-vc) — Series A
- TechAviv (https://capitalatlas.ai/funds/techaviv) — Series A
- Harpoon Ventures (https://capitalatlas.ai/funds/harpoon-ventures) — Series A
- Ajinomoto — Series A
- Pitango Healthtech (https://capitalatlas.ai/funds/pitango-healthtech) — Series A